Natrecor Side Effects Could Result In Heart Failure Lawsuits
Natrecor Side Effects Injury Lawsuits. In a study published in the April 2005 issue of the Journal of the American Medical Association, a team of researchers assert that Natrecor users suffered from a higher death rate than cardiac patients on other drugs, such as diuretics and vasodilators, based on data from three past … [Read more...] about Natrecor Side Effects Could Result In Heart Failure Lawsuits
J&J Reaches $2.2B Risperdal, Invega and Natrecor Settlement
$2.2 Billion Settlement To Resolve Allegations. According to a press release issued by the Department of Justice Office of Public Affairs, Johnson & Johnson and its subsidiaries will pay $2.2 billion to resolve criminal and civil allegations involving the drugs Risperdal, Invega and Natrecor. Civil settlements with state and … [Read more...] about J&J Reaches $2.2B Risperdal, Invega and Natrecor Settlement
Natrecor Illegally Marketed
Natrecor Was Illegally Marketed. The United States Justice Department (DOJ) just announced that it is joining in two whistleblower lawsuits against drug maker Scios Inc. and Johnson & Johnson Inc. (J&J); J&J is Scios’ parent company. The lawsuits allege the drug makers marketed cardiac drug Natrecor for a use … [Read more...] about Natrecor Illegally Marketed
Natrecor a Drag on J&J since Reports of Kidney Failure
Reports of Kidney Failure, Deaths Natrecor side effect reports have taken a toll on the finances of Johnson & Johnson. Natrecor was considered a potential hit in 2001 when the Food and Drug Administration (FDA) approved it for treating severe heart failure. So great was this potential, that in 2003, Johnson & Johnson paid … [Read more...] about Natrecor a Drag on J&J since Reports of Kidney Failure
Scios Safety Study of Natrecor
Scios Safety Study of Natrecor. Scios Inc. announced on Thursday that it would spend more than $100 million to conduct a safety and effectiveness study of its controversial heart failure drug, Natrecor. The trial is designed to address safety issues swirling around the drug since last year when other studies suggested … [Read more...] about Scios Safety Study of Natrecor
Scios Heart Drug Curbed
Scios Heart Drug Natrecor Not Approved By FDA. Fremont biotechnology firm Scios Inc. is taking the first of a series of steps to curb prescribing of its heart drug Natrecor for uses not approved by the Food and Drug Administration. The company, a unit of Johnson & Johnson, had been accused of promoting those unapproved uses by … [Read more...] about Scios Heart Drug Curbed
